200 related articles for article (PubMed ID: 23475171)
1. Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.
Qiu X; Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
Mol Cell Biochem; 2013 Jun; 378(1-2):99-106. PubMed ID: 23475171
[TBL] [Abstract][Full Text] [Related]
2. Expression of SOCSs in human prostate cancer and their association in prognosis.
Zhu JG; Dai QS; Han ZD; He HC; Mo RJ; Chen G; Chen YF; Wu YD; Yang SB; Jiang FN; Chen WH; Sun ZL; Zhong WD
Mol Cell Biochem; 2013 Sep; 381(1-2):51-9. PubMed ID: 23666742
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2.
Ren W; Wu S; Wu Y; Liu T; Zhao X; Li Y
Cell Death Dis; 2019 Apr; 10(5):333. PubMed ID: 30988277
[TBL] [Abstract][Full Text] [Related]
4. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
7. Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer.
Letellier E; Schmitz M; Baig K; Beaume N; Schwartz C; Frasquilho S; Antunes L; Marcon N; Nazarov PV; Vallar L; Even J; Haan S
Br J Cancer; 2014 Aug; 111(4):726-35. PubMed ID: 25025962
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation.
Yang Z; Zhu H; Zhang L; Wei Q; Zhou L; Xu X; Song P; Liu J; Xie H; Zheng S
Mol Biol Rep; 2020 Mar; 47(3):1773-1782. PubMed ID: 32006198
[TBL] [Abstract][Full Text] [Related]
10. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
[TBL] [Abstract][Full Text] [Related]
11. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
[TBL] [Abstract][Full Text] [Related]
12. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
Chen XQ; He JR; Wang HY
Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
[TBL] [Abstract][Full Text] [Related]
14. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
[TBL] [Abstract][Full Text] [Related]
15. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
17. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
18. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
[TBL] [Abstract][Full Text] [Related]
19. MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.
Li ZB; Li ZZ; Li L; Chu HT; Jia M
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3208-17. PubMed ID: 26400524
[TBL] [Abstract][Full Text] [Related]
20. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
